RARX
Dimensional Fund Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-343,215
| Closed | -$16.5M | – | 3412 |
|
|
2020
Q1 | $16.5M | Hold |
343,215
| – | – | 0.01% | 1867 |
|
|
2019
Q4 | $16.1M | Sell |
343,215
-4,024
| -1% | -$189K | 0.01% | 2150 |
|
|
2019
Q3 | $8.21M | Sell |
347,239
-9,615
| -3% | -$227K | ﹤0.01% | 2432 |
|
|
2019
Q2 | $10.7M | Sell |
356,854
-17,219
| -5% | -$518K | ﹤0.01% | 2368 |
|
|
2019
Q1 | $8.38M | Sell |
374,073
-32,047
| -8% | -$718K | ﹤0.01% | 2470 |
|
|
2018
Q4 | $7.39M | Buy |
406,120
+11,941
| +3% | +$217K | ﹤0.01% | 2466 |
|
|
2018
Q3 | $7.13M | Buy |
394,179
+179,600
| +84% | +$3.25M | ﹤0.01% | 2563 |
|
|
2018
Q2 | $2.14M | Buy |
214,579
+46,126
| +27% | +$459K | ﹤0.01% | 2873 |
|
|
2018
Q1 | $894K | Buy |
168,453
+124,750
| +285% | +$662K | ﹤0.01% | 3020 |
|
|
2017
Q4 | $371K | Buy |
+43,703
| New | +$371K | ﹤0.01% | 3134 |
|